{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:55:00Z","timestamp":1772582100949,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00787-025-02851-1","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:13:25Z","timestamp":1756462405000},"page":"427-435","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient characteristics\u2019 moderation of multinutrients treatment response in school-age children with attention deficit hyperactivity disorder"],"prefix":"10.1007","volume":"35","author":[{"given":"Brenda MY","family":"Leung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anupam","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang S.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanette M.","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene E.","family":"Hatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Eugene","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"2851_CR1","doi-asserted-by":"crossref","unstructured":"Espinet SD et al (2022) A review of Canadian diagnosed ADHD prevalence and incidence estimates published in the past decade. Brain Sci 12(8):1051","DOI":"10.3390\/brainsci12081051"},{"key":"2851_CR2","unstructured":"Center for Disease Control and Prevention. Attention Deficit Hyperactivity Disorder, Data and Statistics (2025) March 01 2025 [cited 2025 March 01]; Available from: https:\/\/www.cdc.gov\/adhd\/data\/index.html"},{"issue":"1","key":"2851_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13052-023-01456-1","volume":"49","author":"N Salari","year":"2023","unstructured":"Salari N et al (2023) The global prevalence of ADHD in children and adolescents: a systematic review and meta-analysis. Ital J Pediatr 49(1):48","journal-title":"Ital J Pediatr"},{"key":"2851_CR4","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jad.2023.07.071","volume":"339","author":"G Ayano","year":"2023","unstructured":"Ayano G et al (2023) The global prevalence of attention deficit hyperactivity disorder in children and adolescents: an umbrella review of meta-analyses. J Affect Disord 339:860\u2013866","journal-title":"J Affect Disord"},{"issue":"7","key":"2851_CR5","doi-asserted-by":"publisher","first-page":"e0180355","DOI":"10.1371\/journal.pone.0180355","volume":"12","author":"F Catal\u00e1-L\u00f3pez","year":"2017","unstructured":"Catal\u00e1-L\u00f3pez F et al (2017) The Pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials. PLoS ONE 12(7):e0180355","journal-title":"PLoS ONE"},{"key":"2851_CR6","doi-asserted-by":"crossref","unstructured":"Peterson BS et al (2024) Treatments for ADHD in children and adolescents: A systematic review. Pediatrics 153(4):e2024065787","DOI":"10.1542\/peds.2024-065787"},{"issue":"6","key":"2851_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S2352-4642(22)00381-9","volume":"7","author":"MH Sibley","year":"2023","unstructured":"Sibley MH et al (2023) Non-pharmacological interventions for attention-deficit hyperactivity disorder in children and adolescents. Lancet Child Adolesc Health 7(6):415\u2013428","journal-title":"Lancet Child Adolesc Health"},{"issue":"3","key":"2851_CR8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/jcpp.12817","volume":"59","author":"JJ Rucklidge","year":"2018","unstructured":"Rucklidge JJ et al (2018) Vitamin-mineral treatment improves aggression and emotional regulation in children with ADHD: a fully blinded, randomized, placebo-controlled trial. J Child Psychol Psychiatry 59(3):232\u2013246","journal-title":"J Child Psychol Psychiatry"},{"issue":"5","key":"2851_CR9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jaac.2021.07.005","volume":"61","author":"JM Johnstone","year":"2022","unstructured":"Johnstone JM et al (2022) Micronutrients for Attention-Deficit\/Hyperactivity disorder in youth: A Placebo-Controlled randomized clinical trial. J Am Acad Child Adolesc Psychiatry 61(5):647\u2013661","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2851_CR10","doi-asserted-by":"crossref","unstructured":"Leung BMY et al (2023) Micronutrients for ADHD in youth (MADDY) study: comparison of results from RCT and open label extension. Eur Child Adolesc Psychiatry","DOI":"10.1007\/s00787-023-02236-2"},{"key":"2851_CR11","doi-asserted-by":"publisher","first-page":"100478","DOI":"10.1016\/j.conctc.2019.100478","volume":"16","author":"JM Johnstone","year":"2019","unstructured":"Johnstone JM et al (2019) Rationale and design of an international randomized placebo-controlled trial of a 36-ingredient micronutrient supplement for children with ADHD and irritable mood: the micronutrients for ADHD in youth (MADDY) study. Contemp Clin Trials Commun 16:100478","journal-title":"Contemp Clin Trials Commun"},{"issue":"10","key":"2851_CR12","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1001\/archpsyc.59.10.877","volume":"59","author":"HC Kraemer","year":"2002","unstructured":"Kraemer HC et al (2002) Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry 59(10):877\u2013883","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"2851_CR13","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1002\/sim.5734","volume":"32","author":"HC Kraemer","year":"2013","unstructured":"Kraemer HC (2013) Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach. Stat Med 32(11):1964\u20131973","journal-title":"Stat Med"},{"issue":"10","key":"2851_CR14","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/jama.296.10.1286","volume":"296","author":"HC Kraemer","year":"2006","unstructured":"Kraemer HC, Frank E, Kupfer DJ (2006) Moderators of treatment outcomes: clinical, research, and policy importance. JAMA 296(10):1286\u20131289","journal-title":"JAMA"},{"issue":"2","key":"2851_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11121-011-0221-x","volume":"14","author":"R Wang","year":"2013","unstructured":"Wang R, Ware JH (2013) Detecting moderator effects using subgroup analyses. Prev Sci 14(2):111\u2013120","journal-title":"Prev Sci"},{"issue":"5","key":"2851_CR16","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00787-023-02236-2","volume":"33","author":"BMY Leung","year":"2024","unstructured":"Leung BMY et al (2024) Micronutrients for ADHD in youth (MADDY) study: comparison of results from RCT and open label extension. Eur Child Adolesc Psychiatry 33(5):1355\u20131367","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"7","key":"2851_CR17","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner J, Targum SD (2007) The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont) 4(7):28\u201337","journal-title":"Psychiatry (Edgmont)"},{"key":"2851_CR18","unstructured":"Breiman L et al (1984) Classification and Regression Trees (1st ed.). New York: Chapman and Hall\/CRC"},{"issue":"1","key":"2851_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/widm.8","volume":"1","author":"W-Y Loh","year":"2011","unstructured":"Loh W-Y (2011) Classification and regression trees. WIREs Data Min Knowl Discov 1(1):14\u201323","journal-title":"WIREs Data Min Knowl Discov"},{"key":"2851_CR20","unstructured":"Therneau T, Atkinson B (2025) rpart: Recursive Partitioning and Regression Trees"},{"issue":"2","key":"2851_CR21","doi-asserted-by":"publisher","first-page":"2225151","DOI":"10.1080\/20008066.2023.2225151","volume":"14","author":"EM Fagermoen","year":"2023","unstructured":"Fagermoen EM et al (2023) Parent-led stepped care for traumatised children: parental factors that predict treatment completion and response. Eur J Psychotraumatol 14(2):2225151","journal-title":"Eur J Psychotraumatol"},{"issue":"9","key":"2851_CR22","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/jcpp.13197","volume":"61","author":"FA Torvik","year":"2020","unstructured":"Torvik FA et al (2020) Mechanisms linking parental educational attainment with child ADHD, depression, and academic problems: a study of extended families in the Norwegian mother, father and child cohort study. J Child Psychol Psychiatry 61(9):1009\u20131018","journal-title":"J Child Psychol Psychiatry"},{"key":"2851_CR23","doi-asserted-by":"publisher","first-page":"103707","DOI":"10.1016\/j.nicl.2024.103707","volume":"45","author":"M Chen","year":"2025","unstructured":"Chen M et al (2025) Prediction of methylphenidate treatment response for ADHD using conventional and radiomics T1 and DTI features: secondary analysis of a randomized clinical trial. Neuroimage Clin 45:103707","journal-title":"Neuroimage Clin"},{"key":"2851_CR24","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/archpsyc.1978.01770280073008","volume":"35","author":"LE Arnold","year":"1978","unstructured":"Arnold LE et al (1978) Methylphenidate vs. d\u2013amphetamine vs. caffeine in MBD: controlled comparison by placebo washout design with Bayes analysis. Arch Gen Psychiatry 35:463\u2013473","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"2851_CR25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/108705470000300403","volume":"3","author":"LE Arnold","year":"2000","unstructured":"Arnold LE (2000) Methylphenidate vs. Amphetamine: comparative review. J Atten Disorders 3(4):200\u2013211","journal-title":"J Atten Disorders"},{"issue":"7","key":"2851_CR26","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nrn2421","volume":"9","author":"F G\u00f3mez-Pinilla","year":"2008","unstructured":"G\u00f3mez-Pinilla F (2008) Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci 9(7):568\u2013578","journal-title":"Nat Rev Neurosci"},{"key":"2851_CR27","doi-asserted-by":"crossref","unstructured":"Lange KW (2020) Micronutrients and diets in the treatment of Attention-Deficit\/Hyperactivity disorder: chances and pitfalls. Front Psychiatry 11:102","DOI":"10.3389\/fpsyt.2020.00102"},{"issue":"4","key":"2851_CR28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/mnfr.200900158","volume":"54","author":"D Benton","year":"2010","unstructured":"Benton D (2010) The influence of dietary status on the cognitive performance of children. Mol Nutr Food Res 54(4):457\u2013470","journal-title":"Mol Nutr Food Res"},{"issue":"3","key":"2851_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s13668-023-00487-8","volume":"12","author":"KW Lange","year":"2023","unstructured":"Lange KW et al (2023) Nutrition in the management of ADHD: A review of recent research. Curr Nutr Rep 12(3):383\u2013394","journal-title":"Curr Nutr Rep"},{"issue":"4","key":"2851_CR30","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1080\/15374416.2020.1833337","volume":"50","author":"LA Norris","year":"2021","unstructured":"Norris LA, Kendall PC (2021) Moderators of outcome for youth anxiety treatments: current findings and future directions. J Clin Child Adolesc Psychol 50(4):450\u2013463","journal-title":"J Clin Child Adolesc Psychol"},{"issue":"4","key":"2851_CR31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/1028415X.2023.2191415","volume":"27","author":"LM Robinette","year":"2024","unstructured":"Robinette LM et al (2024) Treatment response to supplemental nutrients for ADHD is independent of diet quality: the MADDY study RCT. Nutr Neurosci 27(4):319\u2013328","journal-title":"Nutr Neurosci"},{"issue":"1","key":"2851_CR32","doi-asserted-by":"publisher","first-page":"2463570","DOI":"10.1080\/19490976.2025.2463570","volume":"17","author":"HK Ast","year":"2025","unstructured":"Ast HK et al (2025) Gut Microbiome changes with micronutrient supplementation in children with attention\u2013deficit\/hyperactivity disorder: the MADDY study. Gut Microbes 17(1):2463570","journal-title":"Gut Microbes"},{"issue":"3","key":"2851_CR33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1017\/S0007114524001132","volume":"132","author":"LM Robinette","year":"2024","unstructured":"Robinette LM et al (2024) Evaluating mineral biomarkers as mediators and moderators of behavioural improvements in a randomised controlled trial of multinutrients for children with attention-deficit\/hyperactivity disorder. Br J Nutr 132(3):315\u2013329","journal-title":"Br J Nutr"},{"key":"2851_CR34","doi-asserted-by":"crossref","unstructured":"Robinette L et al (2025) Multinutrients Decrease Oxidative Stress in Children with ADHD: Mediation\/Moderation Analysis of Randomized Controlled Trial Data. Journal of Attention Disoders, In press","DOI":"10.1177\/10870547251355998"}],"container-title":["European Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-025-02851-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-025-02851-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-025-02851-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:04:01Z","timestamp":1772579041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00787-025-02851-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2851"],"URL":"https:\/\/doi.org\/10.1007\/s00787-025-02851-1","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors have no financial interests or conflicts of interest relevant to this study to disclose. Dr. Arnold has received research funding from Supernus Pharmaceuticals (USA), Roche\/Genentech Pharmaceuticals (Switzerland), Otsuka Pharmaceuticals (Japan), and YoungLiving Essential Oils (USA) and National Institute of Health (USA, R01 MH 100144), has consulted with Pfizer Parmaceuticals (USA), and been on advisory boards for Otsuka (Japan) and Roche\/Genentech (Switzerland).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}